Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Several new drugs have...

    Several new drugs have been developed under AYUSH System: Shri Shripad Naik

    Written by supriya kashyap kashyap Published On 2017-02-08T10:39:15+05:30  |  Updated On 8 Feb 2017 10:39 AM IST
    Several new drugs have been developed under AYUSH System: Shri Shripad Naik

    Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central Council for Research in Homoeopathy (CCRH) has developed 9 drugs out of which 2 are of vegetable origin, 5 are from different strains of Dengue virus and two are of chemical origin. Central Council for Research in Siddha (CCRS) has developed D-5 choornam for the management of Type II Diabetes. In addition Ministry of AYUSH through its Research Councils has undertaken R&D for development of new AYUSH drugs with details as under:-


    Ayurveda




    1. Ayush-QOL RC for improvement of quality of life in cancer patients

    2. Ayush- Manas for Mental retardation in Children

    3. C-1 oil for wound healing

    4. Ayush-Rasayan – A&B for Geriatric Health,

    5. Ayush – D for Diabetes,

    6. Ayush – A for Asthma,

    7. Ayush – PJ – 7 for Dengue


    Unani


    The Central Council for Research in Unani Medicine (CCRUM) has conducted multi – centric clinical trials on four new Unani formulations on Vitiligo, Diabetes Mellitus type – II, Essential Hypertension and Infective Hepatitis. Experimental safety of these drugs has already been established


    The development of new drugs is a standard procedure which involves standardization of raw drug followed by Drug proving, Clinical Verification and Clinical Trial. This is done in the concerned institutes of the Ministry following the prevalent guidelines, through Intra – Mural and collaborative research modes. The whole process as detailed above takes 7 to 8 years or even more, in the normal course.


    This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha.

    AyurvedaAyushCCRASCentral Council for Research in Ayurvedic SciencesDiabetes mellitusHepatitisRheumetoid ArthritisShri Shripad NaikUnani

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok